Related Experiment Videos

Thrombus in right atrium in two infants successfully treated with tissue plasminogen activator

E Martínez-Tallo1, F Campo, M Delgado

  • 1Division of Pediatric Intensive Care and Pediatric Cardiology, Infanta Cristina University Hospital, Badajoz, Spain.

Pediatric Emergency Care
|February 1, 1997
PubMed

Insights

Recombinant tissue-plasminogen activator (rt-PA) effectively dissolved right atrial thrombi in infants treated via central venous catheters. This thrombolytic therapy offers a promising option for pediatric thrombotic complications.

Area of Science:

  • Pediatric Cardiology
  • Hematology
  • Interventional Radiology

Background:

  • Central venous catheters are essential in pediatric care but increase risks of thrombotic complications.
  • Thrombolytic therapy is indicated for significant venous thromboses in children.

Observation:

  • Two infants (4 and 2 months) presented with mobile right atrial thrombi.
  • These thrombi were treated using recombinant tissue-plasminogen activator (rt-PA) delivered through a central venous catheter.

Findings:

  • Complete clot dissolution was achieved in both infants.
  • Resolution times were 8 hours and 44 hours, respectively.
  • One infant experienced transient respiratory distress likely due to pulmonary microembolism.

Implications:

  • Catheter-directed rt-PA infusion is a viable treatment for pediatric right atrial thrombi.
  • This approach may reduce the need for more invasive procedures.
  • Monitoring for potential complications like pulmonary embolism and bleeding is crucial.

Related Concept Videos